Literature DB >> 25953898

Stoichiometry of Heteromeric BAFF and APRIL Cytokines Dictates Their Receptor Binding and Signaling Properties.

Sonia Schuepbach-Mallepell1, Dolon Das1, Laure Willen1, Michele Vigolo1, Aubry Tardivel1, Luc Lebon1, Christine Kowalczyk-Quintas1, Josquin Nys1, Cristian Smulski1, Timothy S Zheng2, Klaus Maskos3, Alfred Lammens3, Xuliang Jiang4, Henry Hess5, Seng-Lai Tan4, Pascal Schneider6.   

Abstract

The closely related TNF family ligands B cell activation factor (BAFF) and a proliferation-inducing ligand (APRIL) serve in the generation and maintenance of mature B-lymphocytes. Both BAFF and APRIL assemble as homotrimers that bind and activate several receptors that they partially share. However, heteromers of BAFF and APRIL that occur in patients with autoimmune diseases are incompletely characterized. The N and C termini of adjacent BAFF or APRIL monomers are spatially close and can be linked to create single-chain homo- or hetero-ligands of defined stoichiometry. Similar to APRIL, heteromers consisting of one BAFF and two APRILs (BAA) bind to the receptors B cell maturation antigen (BCMA), transmembrane activator and CAML interactor (TACI) but not to the BAFF receptor (BAFFR). Heteromers consisting of one APRIL and two BAFF (ABB) bind to TACI and BCMA and weakly to BAFFR in accordance with the analysis of the receptor interaction sites in the crystallographic structure of ABB. Receptor binding correlated with activity in reporter cell line assays specific for BAFFR, TACI, or BCMA. Single-chain BAFF (BBB) and to a lesser extent single-chain ABB, but not APRIL or single-chain BAA, rescued BAFFR-dependent B cell maturation in BAFF-deficient mice. In conclusion, BAFF-APRIL heteromers of different stoichiometries have distinct receptor-binding properties and activities. Based on the observation that heteromers are less active than BAFF, we speculate that their physiological role might be to down-regulate BAFF activity.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  APRIL; BAFF; cytokine; heteromers; immunology; protein engineering; receptor; signaling

Mesh:

Substances:

Year:  2015        PMID: 25953898      PMCID: PMC4481231          DOI: 10.1074/jbc.M115.661405

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

Review 1.  BAFF, APRIL and their receptors: structure, function and signaling.

Authors:  Claudia Bossen; Pascal Schneider
Journal:  Semin Immunol       Date:  2006-08-17       Impact factor: 11.130

2.  TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts.

Authors:  Claudia Bossen; Teresa G Cachero; Aubry Tardivel; Karine Ingold; Laure Willen; Max Dobles; Martin L Scott; Aris Maquelin; Elodie Belnoue; Claire-Anne Siegrist; Stéphane Chevrier; Hans Acha-Orbea; Helen Leung; Fabienne Mackay; Jürg Tschopp; Pascal Schneider
Journal:  Blood       Date:  2007-10-17       Impact factor: 22.113

3.  The TACI receptor regulates T-cell-independent marginal zone B cell responses through innate activation-induced cell death.

Authors:  William A Figgett; Kirsten Fairfax; Fabien B Vincent; Mélanie A Le Page; Indzi Katik; Devy Deliyanti; Pin Shie Quah; Pali Verma; Raelene Grumont; Steve Gerondakis; Paul Hertzog; Lorraine A O'Reilly; Andreas Strasser; Fabienne Mackay
Journal:  Immunity       Date:  2013-09-05       Impact factor: 31.745

4.  A role for BLyS in the activation of innate immune cells.

Authors:  Sook Kyung Chang; Bonnie K Arendt; Jaime R Darce; Xiaosheng Wu; Diane F Jelinek
Journal:  Blood       Date:  2006-07-06       Impact factor: 22.113

5.  BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases.

Authors:  Viktor Roschke; Svetlana Sosnovtseva; Christopher D Ward; June S Hong; Rodger Smith; Vivian Albert; William Stohl; Kevin P Baker; Stephen Ullrich; Bernardetta Nardelli; David M Hilbert; Thi-Sau Migone
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

6.  Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands.

Authors:  Yingfang Liu; Liangguo Xu; Natasha Opalka; John Kappler; Hong Bing Shu; Gongyi Zhang
Journal:  Cell       Date:  2002-02-08       Impact factor: 41.582

7.  A lymphotoxin-beta-specific receptor.

Authors:  P D Crowe; T L VanArsdale; B N Walter; C F Ware; C Hession; B Ehrenfels; J L Browning; W S Din; R G Goodwin; C A Smith
Journal:  Science       Date:  1994-04-29       Impact factor: 47.728

8.  B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation.

Authors:  Svetlana Shulga-Morskaya; Max Dobles; Meghan E Walsh; Lai Guan Ng; Fabienne MacKay; Sambasiva P Rao; Susan L Kalled; Martin L Scott
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

9.  BAFF controls B cell metabolic fitness through a PKC beta- and Akt-dependent mechanism.

Authors:  Alina Patke; Ingrid Mecklenbräuker; Hediye Erdjument-Bromage; Paul Tempst; Alexander Tarakhovsky
Journal:  J Exp Med       Date:  2006-10-23       Impact factor: 14.307

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  15 in total

1.  APRIL:TACI axis is dispensable for the immune response to rabies vaccination.

Authors:  Shannon L Haley; Evgeni P Tzvetkov; Andrew G Lytle; Kishore R Alugupalli; Joseph R Plummer; James P McGettigan
Journal:  Antiviral Res       Date:  2017-06-12       Impact factor: 5.970

Review 2.  The Tumor Necrosis Factor Family: Family Conventions and Private Idiosyncrasies.

Authors:  David Wallach
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-10-01       Impact factor: 10.005

3.  High BAFF expression associated with active disease in systemic lupus erythematosus and relationship with rs9514828C>T polymorphism in TNFSF13B gene.

Authors:  M Marín-Rosales; A Cruz; D C Salazar-Camarena; E Santillán-López; N Espinoza-García; J F Muñoz-Valle; M G Ramírez-Dueñas; E Oregón-Romero; G Orozco-Barocio; C A Palafox-Sánchez
Journal:  Clin Exp Med       Date:  2019-02-11       Impact factor: 5.057

4.  Protein and functional isoform levels and genetic variants of the BAFF and APRIL pathway components in systemic lupus erythematosus.

Authors:  Pilar Ortiz-Aljaro; Marco Antonio Montes-Cano; José-Raúl García-Lozano; Virginia Aquino; Rosario Carmona; Javier Perez-Florido; Francisco José García-Hernández; Joaquín Dopazo; María Francisca González-Escribano
Journal:  Sci Rep       Date:  2022-07-02       Impact factor: 4.996

5.  Antibodies That Block or Activate Mouse B Cell Activating Factor of the Tumor Necrosis Factor (TNF) Family (BAFF), Respectively, Induce B Cell Depletion or B Cell Hyperplasia.

Authors:  Christine Kowalczyk-Quintas; Sonia Schuepbach-Mallepell; Michele Vigolo; Laure Willen; Aubry Tardivel; Cristian R Smulski; Timothy S Zheng; Jennifer Gommerman; Henry Hess; Jacques-Eric Gottenberg; Fabienne Mackay; Olivier Donzé; Pascal Schneider
Journal:  J Biol Chem       Date:  2016-07-22       Impact factor: 5.157

6.  Data for the crystal structure of APRIL-BAFF-BAFF heterotrimer.

Authors:  Klaus Maskos; Alfred Lammens; Seng-Lai Tan; Henry Hess; Wolf Palinsky; Pascal Schneider; Xuliang Jiang
Journal:  Data Brief       Date:  2015-12-18

7.  A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells.

Authors:  Philipp Haselmayer; Michele Vigolo; Josquin Nys; Pascal Schneider; Henry Hess
Journal:  Eur J Immunol       Date:  2017-04-24       Impact factor: 5.532

8.  BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus.

Authors:  Woori Shin; Hyun Tae Lee; Heejin Lim; Sang Hyung Lee; Ji Young Son; Jee Un Lee; Ki-Young Yoo; Seong Eon Ryu; Jaejun Rhie; Ju Yeon Lee; Yong-Seok Heo
Journal:  Nat Commun       Date:  2018-03-23       Impact factor: 14.919

9.  A loop region of BAFF controls B cell survival and regulates recognition by different inhibitors.

Authors:  Michele Vigolo; Melissa G Chambers; Laure Willen; Dehlia Chevalley; Klaus Maskos; Alfred Lammens; Aubry Tardivel; Dolon Das; Christine Kowalczyk-Quintas; Sonia Schuepbach-Mallepell; Cristian R Smulski; Mahya Eslami; Antonius Rolink; Edith Hummler; Eileen Samy; Yves Fomekong Nanfack; Fabienne Mackay; Maofu Liao; Henry Hess; Xuliang Jiang; Pascal Schneider
Journal:  Nat Commun       Date:  2018-03-23       Impact factor: 14.919

Review 10.  BAFF and BAFF-Receptor in B Cell Selection and Survival.

Authors:  Cristian R Smulski; Hermann Eibel
Journal:  Front Immunol       Date:  2018-10-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.